Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-10-06 BARER SOL J Director Conversion · Series C-2 Convertible Preferred Stock −144,086 0
2015-10-06 LOUGHLIN JAMES J Director Conversion +12,261 12,261
2015-10-06 LOUGHLIN JAMES J Director Purchase +7,000 $11.00 $77K 19,261
2015-10-06 LOUGHLIN JAMES J Director Other acquisition +364 $8.60 $3K 19,625
2015-10-06 LOUGHLIN JAMES J Director Conversion · Series C-2 Convertible Preferred Stock −16,774 0
2015-10-06 Spiegel Robert J. Director Conversion +23,579 23,579
2015-10-06 Spiegel Robert J. Director Conversion +10,533 34,112
2015-10-06 Spiegel Robert J. Director Purchase +3,000 $11.00 $33K 37,112
2015-10-06 Spiegel Robert J. Director Other acquisition +1,549 $7.91 $12K 38,661
2015-10-06 Spiegel Robert J. Director Conversion · Series C-1 Convertible Preferred Stock −32,258 0
2015-10-06 Spiegel Robert J. Director Conversion · Series C-2 Convertible Preferred Stock −14,409 0
2015-10-06 HEALY JAMES Director Conversion +1,807,703 1,807,703
2015-10-06 HEALY JAMES Director Purchase +450,000 $11.00 $5.0M 2,257,703
2015-10-06 HEALY JAMES Director Other acquisition +53,665 $8.60 $462K 2,311,368
2015-10-06 HEALY JAMES Director Conversion · Series C-2 Convertible Preferred Stock −2,473,118 0
2015-10-06 Macdonald R. Loch Chief Scientific Officer Conversion +18,274 566,480
2015-10-06 Macdonald R. Loch Chief Scientific Officer Conversion +3,928 570,408
2015-10-06 Macdonald R. Loch Chief Scientific Officer Other acquisition +194 $7.90 $2K 570,602
2015-10-06 Macdonald R. Loch Chief Scientific Officer Conversion · Series A Convertible Preferred Stock −25,000 0
2015-10-06 Macdonald R. Loch Chief Scientific Officer Conversion · Series C-1 Convertible Preferred Stock −5,373 0

Page 16 of 18 · 346 trades